NCT02482818View on ClinicalTrials.gov

Efficacy of Pregabalin on Chronic Cough

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Cough
Interventions
DRUG

Pregabalin

Increasing dose regimen depending on tolerability followed by decreasing dose regimen.

DRUG

Control-Placebo

A control substance, Lactose is administered in place of Pregabalin.

Trial Locations (1)

K1Y 4E9

RECRUITING

The Ottawa Hospital (General and Civic Campuses), Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER